New Edge Advisors, LLC Eli Lilly & CO Transaction History

New Edge Advisors, LLC

$11.2 Billion
Q1 2024

A detailed history of New Edge Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, New Edge Advisors, LLC holds 106,833 shares of LLY stock, worth $82.3 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

106,833

Previous 99,803 7.04%

Holding current value

$82.3 Million

Previous $58.2 Million 42.86%

% of portfolio

0.74%

Previous 0.56%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $4.16 Million - $5.57 Million	7,030 Added 7.04%	106,833 $83.1 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $13.8 Million - $16.3 Million	26,309 Added 35.8%	99,803 $58.2 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $2.63 Million - $3.62 Million	6,043 Added 8.96%	73,494 $39.5 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $696,920 - $931,863	1,987 Added 3.04%	67,451 $31.6 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $993,705 - $1.17 Million	-3,199 Reduced 4.66%	65,464 $22.5 Million

Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $2.41 Million - $2.81 Million	7,498 Added 12.26%	68,663 $25.1 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $389,278 - $443,623	-1,313 Reduced 2.1%	61,165 $19.8 Million
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $2.63 Million - $3.08 Million	9,426 Added 17.77%	62,478 $20.3 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $1.12 Million - $1.39 Million	4,774 Added 9.89%	53,052 $15.2 Million
Q4 2021 Feb 17, 2022	BUY	$224.85 - $279.04 $2.35 Million - $2.92 Million	10,456 Added 27.65%	48,278 $13.3 Million
Q3 2021 Oct 29, 2021	BUY	$221.6 - $272.71 $1.28 Million - $1.58 Million	5,795 Added 18.09%	37,822 $8.74 Million
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $106,885 - $138,255	592 Added 1.88%	32,027 $7.35 Million
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $811,576 - $1.05 Million	-4,939 Reduced 13.58%	31,435 $5.87 Million
Q4 2020 Jan 27, 2021	SELL	$130.46 - $172.63 $13.9 Million - $18.4 Million	-106,714 Reduced 74.58%	36,374 $6.14 Million
Q3 2020 Nov 03, 2020	BUY	$146.22 - $169.13 $15.4 Million - $17.8 Million	105,145 Added 277.11%	143,088 $21.2 Million
Q2 2020 Jul 29, 2020	BUY	$136.42 - $164.18 $254,968 - $306,852	1,869 Added 5.18%	37,943 $6.23 Million
Q1 2020 May 04, 2020	BUY	$119.05 - $147.35 $596,321 - $738,076	5,009 Added 16.12%	36,074 $5 Million
Q4 2019 Jan 31, 2020	SELL	$106.92 - $132.43 $19,352 - $23,969	-181 Reduced 0.58%	31,065 $4.08 Million
Q3 2019 Nov 06, 2019	BUY	$106.79 - $116.16 $2.04 Million - $2.22 Million	19,108 Added 157.42%	31,246 $3.43 Million
Q2 2019 Aug 05, 2019	BUY	$110.79 - $129.32 $26,700 - $31,166	241 Added 2.03%	12,138 $1.35 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $1.74 Million - $2.05 Million	-15,644 Reduced 56.8%	11,897 $1.54 Million
Q1 2019 May 09, 2019	BUY	$111.31 - $131.02 $1.72 Million - $2.03 Million	15,472 Added 128.2%	27,541 $17,000
Q4 2018 Jan 29, 2019	BUY	$105.9 - $118.64 $96,580 - $108,199	912 Added 8.17%	12,069 $1.4 Million
Q3 2018 Oct 29, 2018	SELL	$85.86 - $107.31 $29,192 - $36,485	-340 Reduced 2.96%	11,157 $1.2 Million
Q2 2018 Jul 19, 2018	SELL	$75.7 - $86.88 $7.3 Million - $8.37 Million	-96,377 Reduced 89.34%	11,497 $987,000
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $1.4 Million - $1.66 Million	18,918 Added 21.27%	107,874 $8.17 Million
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $518,188 - $555,816	6,324 Added 7.65%	88,956 $7.66 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $4.57 Million - $5.07 Million	59,255 Added 253.48%	82,632 $7.19 Million
Q2 2017 Aug 16, 2017	BUY	N/A	23,377	23,377 $0

Others Institutions Holding LLY

# of Institutions

3,703

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $732B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Eli Lilly & CO Transaction History